Eros Papademetriou

6PUBLICATIONS
7CO-AUTHORS
Panel data analysisProsthetics and orthoticsCancer therapy (excl. chemotherapy and radiation therapy)PharmacogenomicsBanking, finance and securities law
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 21, 2026
Economic burden associated with switching from frontline pegaspargase or calaspargase pegol to second-line recombinant Erwinia in pediatrics and adolescents/young adults with acute lymphoblastic leukemia.

|Aug 14, 2024
Adherence, Persistence, Healthcare Resource Use, and Costs in Tofacitinib-Treated Patients with Psoriatic Arthritis: Data from Two United States Claims Databases.

Philip J Mease, Eros Papademetriou, Ravi Potluri

|Oct 25, 2023
Work loss and activity impairment due to extended nausea and vomiting in patients with breast cancer receiving CINV prophylaxis.

Lee Schwartzberg, Rudolph M Navari, Kathryn J Ruddy

|Apr 22, 2023
Comparative evaluation of costs and healthcare resource utilization of oral selexipag versus inhaled treprostinil or oral treprostinil in patients with pulmonary arterial hypertension.

Eros Papademetriou, Xing Liu, Amélie Beaudet

|Dec 17, 2022
Duration of Chemotherapy-Induced Nausea and Vomiting (CINV) as a Predictor of Recurrent CINV in Later Cycles.

Rudolph Navari, Gary Binder, Alex Molasiotis

|Oct 20, 2021
Economic burden to commercial payers of young adults with schizophrenia in Colorado.

Jacqueline Pesa, Charmi Patel, David Rotter

Pageof 1

Frequent Collaborators

2 joint publications

Ravi Potluri

1 joint publications

David Rotter

1 joint publications

Philip J Mease

1 joint publications

Joseph C Cappelleri